A bayesian approach to subgroup identification

Journal of Biopharmaceutical Statistics

Volumn 24, Issue 1, 2014, Pages 110-129

  Berger, James O ^a   Wang, Xiaojing ^b   Shen, Lei ^c  

^a Duke University   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Bayesian analysis; Model uncertainty; Multiplicity; Subgroup analysis

Indexed keywords

PLACEBO;

ARTICLE; BAYES THEOREM; DISEASE COURSE; EFFECT SIZE; HUMAN; OUTCOME VARIABLE; PERSONALIZED MEDICINE; POPULATION RESEARCH; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RESPONSE VARIABLE; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SUBGROUP IDENTIFICATION;

ALGORITHMS; BAYES THEOREM; CLINICAL TRIALS AS TOPIC; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, STATISTICAL; PATIENT SELECTION; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84891759350     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2013.856026     Document Type: Article

References (26)

1. Berry, D. A. (1990). Subgroup analyses. Biometrics 46:1227-1230.
2. Cui, L., James Hung, H. M., Wang, S. J., Tsong, Y. (2002). Issues related to subgroup analysis in clincial trials. Journal of Biopharmaceutical Statistics 12:347-358.
3. Dixon, D. O., Simon, R. (1991). Bayesian subset analysis. Biometrics 47:871-881.
4. Foster, J. C., Taylor, J. M., Ruberg, S. J. (2011). Subgroup identification from randomized clinical trial data. Statistics in Medicine 30:2867-2880.
5. Hodges, J. S., Cui, Y., Sargent, D. J., Carlin, B. P. (2007). Smoothing balanced single-errorterm analysis of variance. Technometrics 49:12-25.
6. Jones, H. E., Ohlssen, D. I., Neuenschwander, B., Racine, A., Branson, M. (2011). Bayesian models for subgroup analysis in clinical trials. Clinical Trials 8:129-143.
7. Lagakos, S. (2006). The challenge of subgroup analyses-reporting without distorting. New England Journal of Medicine 354:1667-1669.
8. Laud, P. W., Sivaganesan, S., Müller, P. (2013). Subgroup analysis. In: Damien, P., Dellaportas, P., Polson, N., Stephens, D., eds. Bayesian Theory and Applications. Oxford, UK: Oxford University Press, pp. 576-592.
9. Lavedan, C., Volpi, S., Polymeropoulos, M. H., Wolfgang, C. D. (2008). Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial. Pharmacogenomics 9:289-301.
10. Lipkovich, I., Dmitrienko, A., Denne, J., Enas, G. (2011). Subgroup identification based on differential effect search - A recursive partitioning method for establishing response to treatment in patient subpopulations. Statistics in Medicine 30:2601-2621.
11. Liu, W., Downing, A. C. M., Munsie, L. M., Chen, P., Reed, M. R., Ruble, C. L., Landschulz, K. T., Kinon, B. J., Nisenbaum, L. K. (2012). Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia. The Pharmacogenomics Journal 12:246-254.
12. Negassa, A., Ciampi, A., Abrahamowicz, M., Shapiro, S., Boivin, J.-F. (2005). Treestructured subgroup analysis for censored survival data: Validation of computationally inexpensive model selection criteria. Statistics and Computing 15:231-239.
13. Pocock, S. J., Assmann, S. E., Enos, L. E., Kasten, L. E. (2002). Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Statistics in Medicine 21:2917-2930.
14. Ruberg, S. J., Chen, L., Wang, Y. (2010). The mean does not mean as much anymore: Finding sub-groups for tailored therapeutics. Clinical Trials 7:574-583.
15. Schwarz, G. (1978). Estimating the dimension of a model. The Annals of Statistics 6:461-464.
16. Scott, J. G., Berger, J. O. (2010). Bayes and empirical-Bayes multiplicity adjustment in the variable-selection problem. Annals of Statistics 38:2587-2619.
17. Sellke, T., Bayarri, M. J., Berger, J. (2001). Calibration of p-values for testing precise null hypotheses. The American Statistician 55:62-71.
18. Simon, R. (2002). Bayesian subset analysis: Application to studying treatment-by-gender interactions. Statistics in Medicine 21:2909-2916.
19. Sivaganesan, S., Laud, P. W., Müller, P. (2011). A Bayesian subgroup analysis with a zeroenriched Polya urn scheme. Statistics in Medicine 30:312-323.
20. Su, X., Zhou, T., Yan, X., Fan, J., Yang, S. (2008). Interaction trees with censored survival data. The International Journal of Biostatistics 4:1-26.
21. Su, X., Tsai, C.-L., Wang, H., Nickerson, D. M., Li, B. (2009). Subgroup analysis via recursive partitioning. Journal of Machine Learning Research 10:141-158.
22. Temple, R., Ellenberg, S. S. (2000). Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Annals of Internal Medicine 133:464-470.
23. Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., Drazen, J. M. (2007). Statistics in medicine - reporting of subgroup analyses in clinical trials. New England Journal of Medicine 357:2189-2194.
24. Wang, X. (2012). Bayesian Modeling Using Latent Structures. Ph.D. thesis, Duke University.
25. Westfall, P. H., Johnson, W. O., Utts, J. M. (1997). A Bayesian perspective on the Bonferroni adjustment. Biometrika 84:419-427.
26. Woodcock, J. (2007). The prospects for "personalized medicine" in drug development and drug therapy. Clinical Pharmacology and Therapeutics 81:164-169.